Leisure Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Leisure Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-28,441	Closed	-$170K	–	104
2016 Q2	$170K	Buy	28,441 +36	+0.1%	+$200	0.17%	94
2016 Q1	$129K	Sell	28,405 -8,300	-23%	-$36.9K	0.13%	92
2015 Q4	$165K	Buy	36,705 +878	+2%	+$3.71K	0.15%	95
2015 Q3	$114K	Buy	35,827 +1,209	+3%	+$3.67K	0.12%	88
2015 Q2	$105K	Buy	34,618 +2,101	+6%	+$5.91K	0.1%	94
2015 Q1	$96K	Buy	+32,517	New	+$106K	0.09%	94

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Leisure Capital Management's ENZ Position: Q3 2016 in Review

Leisure Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2016, closing a stake of 28,441 shares — an estimated $170K sold.

Leisure Capital Management first reported a position in ENZ in Q1 2015 and held it in 6 quarters. The position peaked at $170K in Q2 2016. 111 funds tracked by Wall St. Rank hold ENZ as of Q3 2016.

Leisure Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2016 after selling out during the quarter.
Leisure Capital Management sold 28,441 Enzo Biochem, Inc. shares in Q3 2016, an estimated $170K.
Leisure Capital Management first reported a position in Enzo Biochem, Inc. in Q1 2015 and held it in 6 quarters.
Leisure Capital Management's Enzo Biochem, Inc. position peaked at $170K in Q2 2016.
111 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2016.

Based on Leisure Capital Management's 13F filing for Q3 2016, filed 1 Nov 2016.